Our findings partially align with those of the PARROT (placental growth factor-based testing in women with suspected preterm pre-eclampsia) trials, which evaluated the effectiveness of PlGF-based management using an algorithm for women with suspected preeclampsia.24,25 An important finding of the first PARROT trial25 was a reduction in time-to-preeclampsia diagnosis. This evidence concerns the gene PGF and preeclampsia.